Hervé Bonnefoi Selected Research

Aftercare (After-Treatment)

8/2015

Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hervé Bonnefoi Research Topics

Disease

47	Breast Neoplasms (Breast Cancer) 12/2023 - 05/2003
14	Neoplasms (Cancer) 10/2022 - 01/2007
7	Triple Negative Breast Neoplasms 12/2023 - 07/2014
3	Fatigue 11/2023 - 10/2017
2	Vomiting 01/2020 - 10/2017
2	Residual Neoplasm 01/2020 - 01/2016
2	Nausea 01/2020 - 10/2017
2	Neoplasm Metastasis (Metastasis) 08/2017 - 01/2007
1	Pathologic Complete Response 01/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Lobular Carcinoma 01/2021
1	Ductal Carcinoma 01/2021
1	Constipation 01/2020
1	Breast Diseases (Breast Disease) 01/2020
1	Headache (Headaches) 10/2017
1	Asthenia 10/2017
1	Diarrhea 10/2017
1	Infections 01/2017
1	Thrombotic Microangiopathies 01/2016
1	Inflammatory Breast Neoplasms 01/2016
1	Obesity 11/2012
1	Carcinogenesis 01/2007
1	Lymphatic Metastasis 01/2004

Drug/Important Bio-Agent (IBA)

11	Hormones (Hormone)IBA 11/2023 - 07/2014
10	Trastuzumab (Herceptin)FDA Link 10/2023 - 03/2009
8	taxaneIBA 10/2023 - 01/2004
8	human ERBB2 proteinIBA 01/2023 - 01/2017
7	ErbB Receptors (EGF Receptor)IBA 11/2023 - 01/2017
7	Estrogen ReceptorsIBA 11/2021 - 01/2009
5	Androgen Receptors (Androgen Receptor)IBA 12/2023 - 11/2018
5	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2016
4	Carboplatin (JM8)FDA LinkGeneric 12/2023 - 11/2015
4	pertuzumabIBA 10/2023 - 02/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 11/2015
3	AnthracyclinesIBA 10/2022 - 06/2011
3	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 03/2014
3	Letrozole (Femara)FDA LinkGeneric 02/2021 - 11/2012
3	Tamoxifen FDA LinkGeneric 02/2021 - 11/2012
3	Fulvestrant (Faslodex)FDA Link 01/2020 - 08/2015
2	durvalumabIBA 12/2023 - 11/2023
2	palbociclibIBA 11/2023 - 10/2021
2	Taxoids (Taxanes)IBA 10/2022 - 06/2011
2	Ado-Trastuzumab EmtansineIBA 10/2022 - 01/2020
2	Anastrozole (Arimidex)FDA LinkGeneric 01/2020 - 08/2015
2	iniparibIBA 09/2019 - 11/2015
2	Gemcitabine FDA Link 09/2019 - 11/2015
2	Abiraterone AcetateIBA 01/2019 - 11/2018
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2017 - 03/2009
2	Docetaxel (Taxotere)FDA Link 06/2011 - 12/2007
2	Epirubicin (Ellence)FDA LinkGeneric 06/2011 - 12/2007
2	Fluorouracil (Carac)FDA LinkGeneric 06/2011 - 12/2007
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2011 - 12/2007
1	Androgen Antagonists (Antiandrogens)IBA 12/2023
1	Maytansine (Maitansine)IBA 10/2023
1	Aromatase InhibitorsIBA 02/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	pembrolizumabIBA 01/2019
1	Progesterone FDA LinkGeneric 01/2019
1	B7-H1 AntigenIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	ParaffinIBA 01/2019
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 10/2017
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 10/2017
1	NucleotidesIBA 08/2017
1	LigandsIBA 01/2017
1	InterferonsIBA 01/2017
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 01/2017
1	Bombesin Receptors (Bombesin Receptor)IBA 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2016
1	Biological FactorsIBA 12/2013
1	Estrogen Receptor alphaIBA 01/2007

Therapy/Procedure

18	Neoadjuvant Therapy 01/2023 - 12/2007
14	Therapeutics 11/2023 - 09/2004
9	Drug Therapy (Chemotherapy) 10/2023 - 05/2003
4	Adjuvant Chemotherapy 02/2019 - 01/2016
2	Radiotherapy 01/2022 - 01/2004
2	Mastectomy (Mammectomy) 01/2022 - 04/2015
2	Mammaplasty (Breast Reconstruction) 01/2022 - 01/2007
1	Immunotherapy 11/2023
1	Aftercare (After-Treatment) 08/2015
1	Segmental Mastectomy (Lumpectomy) 08/2015
1	Lymph Node Excision (Lymph Node Dissection) 01/2004